|
INTS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.5174999963038E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.589800E-01 |
| Stage1-vs-Stage3 |
2.321400E-01 |
| Stage1-vs-Stage4 |
1.897740E-03 |
| Stage2-vs-Stage3 |
8.675700E-02 |
| Stage2-vs-Stage4 |
4.861600E-03 |
| Stage3-vs-Stage4 |
7.639600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.78159999478333E-08 |
| Normal-vs-Asian |
1.48430046031933E-10 |
| Caucasian-vs-AfricanAmerican |
9.512000E-01 |
| Caucasian-vs-Asian |
8.917800E-01 |
| AfricanAmerican-vs-Asian |
9.716800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62547753035369E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.121700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.783600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.165800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.586600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.340400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.815400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.019200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.441600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.385770E-02 |
| Classical-VS-Follicular |
7.425400E-01 |
| Classical-VS-Other |
1.572750E-01 |
| Classical-VS-Normal |
1.45827794284514E-12 |
| Tall-VS-Follicular |
4.746200E-02 |
| Tall-VS-Other |
8.789400E-01 |
| Tall-VS-Normal |
1.73761005584083E-12 |
| Follicular-VS-Other |
3.144800E-01 |
| Follicular-VS-Normal |
1.01260111406987E-11 |
| Other-VS-Normal |
3.876199999997E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
3.56381590904675E-14 |
| N0-vs-N1 |
1.268050E-01 |
|
|
